Chapter 13: Future tasks of JPGL

Abstract

Since its first edition in 2000, each revision of the Japanese Pediatric Guidelines for the Treatment and Management of Asthma has progressed in response to the final statement on future issues in the previous editions. This year, 9 issues were listed, and examples of future research questions were also provided.

1) Further development as an EBM guideline and more evidence "from Japan" should be obtained; 2) Diagnostic criteria and treatment guidelines for infantile asthma should be clarified; 3) For better transitional care, more evidence on asthma in adolescents and young adults is needed, 4) Criteria for selection and discontinuation of biologics should be clarified; 5) Positioning of allergen immunotherapy in asthma treatment; 6) Development of better biomarkers for treatment selection and elucidation of asthma pathophysiology; 7) Comprehensive asthma care including comorbid allergic diseases such as allergic rhinitis; 8) The need for a comprehensive asthma care system; 9) Establishment of comprehensive treatment scheme of asthma and comorbid allergic diseases such as allergic rhinitis. 8) Further research on respiratory infections that are closely related to the onset and exacerbation of asthma, and a 'novel' concept of infection control in asthma care, which was highlighted by the COVID-19 pandemic, and 9) Further promotion of equalization of asthma care based on the Basic Law on Allergic Disease Control and Prevention.